Dr. Yi Xuan currently is at the McGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. He received his Ph.D. in material science from Tokyo Institute of Technology, Japan. After graduation, he joined the National Institute of Advanced Industrial Science and Technology (AIST) in Tsukuba, Japan, where he worked on a national project to develop 45nm Si CMOS HKMG. Prior to joining the McGowan Institute, he was an Assistant Professor of Surgery at the Indiana University School of Medicine and Associate Director of Biomedical Engineering at the Indiana Center for Regenerative Medicine and Engineering (ICRME). He also worked at Purdue University on various projects such as nanofabrication, nanoelectronics, and nanophotonics. Currently, his research focuses on developing the next generation of tissue nanotransfection (TNT) devices, nanochips for exosome detection, and novel biochips for wound healing applications. He has authored and co-authored more than 100 publications.
Dr. Subhadip Ghatak currently is at the McGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. He has a doctoral degree in biochemistry, specifically on the mechanisms of liver injury and repair in xenobiotic-induced toxicity, from West Bengal University of Health Sciences, India. Before joining the McGowan Institute and the University of Pittsburgh, he was an Assistant Professor of Surgery at the Indiana Center for Regenerative Medicine and Engineering (ICRME). He completed his post-doctoral research at The Ohio State University on the mechanism of tissue plasticity and the role of microRNA (miRNA) as it relates to regenerative healing in adults. He was actively involved in the development of a novel non-invasive non-viral tissue nanotransfection platform. He developed specialized genetic tools for the cell-specific labeling of exosomes in order to study the significance of intercellular crosstalk in tissue regeneration and repair. He has served as principal investigator for an NIH-funded R56 grant and has contributed to 30 peer-reviewed publications. He currently serves as an editorial board member for Frontiers in Medicine and Antioxidants & Redox Signaling and is a junior editor for Extracellular Vesicles and Circulating Nucleic Acids.
Prof. Dr. Chandan K Sen is a tenured Professor of Surgery, Executive Director of The Ohio State University Comprehensive Wound Center and Director of the Ohio State University's Center for Regenerative Medicine & Cell Based Therapies. He is also the Associate Dean for Research at The Ohio State University Wexner Medical Center. He serves as a program director (Innovation & Collaboratory) for The Ohio State University's Center for Clinical and Translational Science, and he serves on the editorial board of numerous scientific journals. His current research on tissue injury and repair is split into three programs: stroke, nuclear reprogramming, and cutaneous wound healing. He is a PI of several projects including multiple clinical trials. His research has been continuously extramurally funded by prestigious agencies such as five different institutes of the National Institutes of Health, the US Department of Defense, the US Department of Veteran Affairs and the industry.
